| Mrs Angela Johns, RN, BSN, CCM | |
|
600 Vestavia Pkwy Ste 200, Vestavia, AL 35216-3756 | |
| (205) 823-2810 | |
| Not Available |
| Full Name | Mrs Angela Johns |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Case Management |
| Location | 600 Vestavia Pkwy Ste 200, Vestavia, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780396317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0400X | Registered Nurse - Case Management | 1-095105 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Angela Johns, RN, BSN, CCM 600 Vestavia Pkwy Ste 200, Vestavia, AL 35216-3756 Ph: (205) 823-2810 | Mrs Angela Johns, RN, BSN, CCM 600 Vestavia Pkwy Ste 200, Vestavia, AL 35216-3756 Ph: (205) 823-2810 |
News Archive
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell $30 million of shares of its Series 2 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to a single institutional investor. Each share of Series 2 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 628 shares of common stock at a conversion price of $1.59125 per share of common stock for a total of approximately 18,853,103 common shares.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
Youth exposure to alcohol advertising on U.S. television increased 71 percent between 2001 and 2009, according to a report released today by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.
An article published in Experimental Biology and Medicine identifies Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS).
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.
› Verified 2 days ago
Ms. Carolyn A Sexton, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Lake Colony Dr, Vestavia, AL 35242 Phone: 205-914-4234 | |
Hilary Higginbotham Swafford, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2868 Acton Rd, Vestavia, AL 35243 Phone: 205-332-3160 | |
Mrs. Sarah E Kilgore, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2613 Vestavia Forest Ter, Vestavia, AL 35216 Phone: 205-568-1525 | |
Allison Lee Beckwith, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr, Vestavia, AL 35243 Phone: 205-977-1949 | |
Owen David Hargett, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-726-2401 | |
Grace Victoria Sandoval, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2871 Acton Rd Ste 101, Vestavia, AL 35243 Phone: 205-612-5009 | |
Lindsay Horn, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 |